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Abstract
We introduce the QuanSA method for inducing physically meaningful field-based models of ligand binding pockets based 
on structure-activity data alone. The method is closely related to the QMOD approach, substituting a learned scoring field 
for a pocket constructed of molecular fragments. The problem of mutual ligand alignment is addressed in a general way, and 
optimal model parameters and ligand poses are identified through multiple-instance machine learning. We provide algorith-
mic details along with performance results on sixteen structure-activity data sets covering many pharmaceutically relevant 
targets. In particular, we show how models initially induced from small data sets can extrapolatively identify potent new 
ligands with novel underlying scaffolds with very high specificity. Further, we show that combining predictions from QuanSA 
models with those from physics-based simulation approaches is synergistic. QuanSA predictions yield binding affinities, 
explicit estimates of ligand strain, associated ligand pose families, and estimates of structural novelty and confidence. The 
method is applicable for fine-grained lead optimization as well as potent new lead identification.
Keywords QSAR · Binding affinity · Machine learning · Multiple-instance learning · Free-energy perturbation · Pose 
prediction · Confidence estimation
Introduction
Binding affinity prediction continues to be a challenge for 
computer-aided drug design, especially in the case where 
there is no high-resolution experimental structure of the 
target of interest. Experimental structure determination 
remains challenging for many pharmaceutical targets such as 
ligand-gated ion channels, membrane transporters, and (now 
to a lesser extent) membrane-spanning G-protein coupled 
receptors. The most widely used methods for activity pre-
diction in such cases include field-based approaches such as 
CoMFA (and variants such as CoMSIA, Topomer CoMFA, 
and CMF) [1–4], pharmacophoric approaches (e.g. Catalyst 
and Phase) [5–9], and descriptor-based approaches [10, 11]. 
These methods vary in the degree to which they parallel 
what is known physically about protein-ligand interactions.
A key attraction of simulation oriented physics-based 
methods, such as MM/PBSA or MM/GBSA [12–15] or 
free-energy perturbation (FEP) [16–18], is that, in principle, 
these approaches are congruent with what we know physi-
cally. For the former methods, in the case where experimen-
tal structures are known for all ligands under consideration, 
performance can be quite variable based on the specific pro-
tein target (Pearson’s r 2 range of 0.0–0.8 for individual pro-
teins) [19], though careful work has shown more consistent 
results in some cases (r2 of 0.5–0.6 for three enzyme targets) 
[14]. For the FEP approach, affinity predictions are made by 
estimating the difference in the free energy of protein-ligand 
complexes between closely-related ligand pairs (typically 
just a few substituent atoms are different). Recent advances 
in force-fields, sampling methods, and automated design 
of perturbation graphs [18] have yielded results that offer 
guidance in fine-grained molecular optimization. For single 
perturbations of a few atoms, errors in predicting changes in 
free energy were approximately 0.9 kcal/mol.
QSAR approaches are not restricted to cases where exper-
imentally determined structures are available; they can be 
applied purely from structure and activity data. However, 
model construction based on correlative considerations 
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rather than causative ones may explain the frequent dis-
appointment in real-world accuracy of QSAR predictions 
[20]. We believe that improvements in predictive power for 
3D-QSAR methods will follow if methods directly address 
key physical phenomena that are observed in protein-ligand 
interactions (see [21] for a more detailed discussion): 1) 
choice of ligand poses must be defined by the model; 2) 
the effects of substituent changes on a central scaffold may 
not be additive [22]; 3) changes in ligand structures induce 
changes in ligand pose relative to a binding pocket; and 4) 
molecular activity may depend upon detailed shape comple-
mentarity between pocket and ligand.
We introduce a new machine-learning method for induc-
tion of models from structure-activity data: Quantitative 
Surface-field Analysis (QuanSA). It is related to the QMOD 
approach [23–27], but rather than constructing a pocket 
composed of molecular fragments, the method constructs a 
“pocket-field” that is still physical in nature. Figure 1 illus-
trates model induction using the benzodiazepine binding site 
(BZR) of the GABAA receptor as an example. Beginning 
with pure SAR data (here SMILES strings and associated 
pKi  measurements), low-energy conformational ensembles 
are produced, from which multiple mutual ligand alignments 
are automatically constructed. Each such alignment contains 
a single optimal pose for each training ligand along with 
many related poses.
The final model (lower left of Fig. 1) has the property 
that each training ligand in its optimal pose (that which 
maximizes its score within the model) has a score that is 
close to the experimental activity. The parameters of the 
pocket-field are depicted by the numerous thin colored 
sticks in the lower left of Fig. 1 (described in detailed 
later). These parameters define the shapes of response 
functions located at observer points in a fixed reference 
frame around the molecules (shown as yellow spheres and 
circles in Figs. 2 and 3).
The colored sticks at the bottom right of Fig. 1 indicate 
the magnitude of the scores attributable to the local por-
tions of the molecule from the observers in that area, with 
the overall ligand score coming from a sum across the 
response functions. The score takes molecular strain into 
account directly, reflecting the degree to which a ligand’s 
predicted pose deviates from the identified global mini-
mum (using a variant of MMFF94s, implemented within 
Fig. 1  Model induction is fully 
automatic, beginning with pure 
structure-activity data (top, 
SMILES and pK i  ), generation 
of core alignments for diverse 
active ligands and elaboration 
into full pose cliques (middle, 
single poses shown without 
variations), and derivation of a 
final pocket-field model (lower 
left), which exhibits adapta-
tion of training ligand poses 
to the induced model based on 
optimizing interactions with 
the model (lower right, initial 
(cyan) and final (gray) poses of 
meclonazepam are shown).
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the ForceGen conformer elaboration approach [28]). The 
final optimal pose of a ligand is typically close to, but 
not identical to, one of the initial poses from the original 
alignment process (the final pose in gray carbons com-
pared to the initial pose in cyan carbons) at the bottom 
right of Fig. 1).
Figure 2 shows two canonical molecules from the ster-
oid QSAR benchmark introduced by Cramer in the original 
CoMFA paper [1] (the carrier protein previously termed 
testosterone binding globulin (TBG) is now termed sex-
hormone binding globulin (SHBG)). The twenty training 
molecules are shown in the single highest-scoring clique 
of one pose per molecule (lower left), all of which make a 
non-controversial superimposition of the steroid core struc-
ture. However, as seen among the variant poses of one mol-
ecule (lower middle, cyan and gray carbons), an alternative 
orientation, flipped both vertically and horizontally, is also 
produced by the similarity-based alignment procedure. As 
pointed out by Cherkasov et al. [29], depending on the par-
ticular steroid ligand, both orientations have been observed 
crystallographically in bound complexes with SHBG.
Fig. 2  Canonical molecules from the globulin binding sets (top); optimal clique of single poses for each molecule (bottom left); all variants for a 
single molecule (bottom middle); and the observer points shown in relation to the most active SHBG molecules (bottom right).
Fig. 3  The response functions 
for QuanSA are computed from 
observer points (yellow circles); 
the functions are responsive to 
molecular shape, hydrogen bond 
donor/acceptor arrangement 
(including directionality); and 
electrostatic field.
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Figure 3 illustrates the functional form of the induced 
field. At each of the observer points (yellow spheres from 
Fig. 2), the minimum distance to the molecular surface is 
calculated, as is the distance and directional congruence to 
the nearest hydrogen bond donor and acceptor (precisely 
as in the morphological similarity method [30]). Addition-
ally, the electrostatic potential energy of a fixed-magnitude 
point charge moved from infinity to the observer position is 
calculated. So, at each feature point, there are six calculated 
values: one which measures pure shape by minimum surface 
distance; two for each donor/acceptor ligand atomic surface 
which measure distance and directionality; and one respon-
sive to local ligand charge.
The response functions are specific to each type of meas-
ured value, and each are parameterized according to the 
SAR data. The combination Gaussian/sigmoid is computed 
from the pure shape measurement, with the minimum sur-
face distance at a particular observer point corresponding to 
the location along the learned curve. The directional polar 
measurements feed into strictly Gaussian terms, with the 
distance driving the location within the Gaussian and the 
directionality modulating the height, with the preferred loca-
tion and maximal height being learned from the data. The 
Coulombic local ligand charge measurement feeds into the 
learned sigmoidal curve.
The sum over all observers of non-linear functions of 
these values forms the pocket-field score. The parameters of 
these functions are estimated during the learning process. As 
with the QMOD and Compass approaches [31–33], model 
refinement proceeds iteratively along with pose refinement 
with respect to the evolving model.
Figure 4 shows the relationship between the induced 
QuanSA pocket-field and the SHBG binding pocket. At left, 
we see the top-scoring pose for DHT along with the interac-
tions made with the pocket-field. There is good correspond-
ence between the hydrophobic interactions (gray sticks) and 
the pocket formed by hydrophobic residues such as pheny-
lalanine, methionine, and valine. The precise geometry and 
direction of the polar interactions differ somewhat from the 
crystal structure, most obviously at the upper right, where 
the orientation of the hydroxyl on DHT is flipped relative to 
what one would expect from the presence of the carboxylate 
in the pocket. In the middle panel, we see that the orientation 
of estradiol is flipped from DHT in its bound pose, deter-
mined experimentally. While the top-scoring predicted pose 
of estradiol lines up the steroid core with that of DHT, the 
set of 25 top-scoring poses includes both orientations. The 
highest scoring “reversed” pose of estradiol was just 1.3 log 
units (in terms of pKd ) lower than the best pose (shown in 
the rightmost panel).
We present details of the QuanSA algorithms and results 
on multiple data sets, including two with particular signifi-
cance from a QSAR benchmarking perspective, eight from 
a validation report for free-energy perturbation, four from 
a recent benchmark where QuanSA pocket-fields were also 
applied to extensive ChEMBL data, and one case of par-
ticular pharmaceutical interest where model refinement was 
explored. Results were consistently better than those from 
prior reports on the same benchmarks using other QSAR 
approaches. A particularly interesting aspect of the physics-
based benchmark was that QuanSA performance was quanti-
tatively very close, but the errors between the methods were 
Fig. 4  Comparison of pocket-field interactions for the top predicted 
ligand pose of DHT (left, steric interactions in gray sticks, ligand 
acceptor to protein donor in red sticks, ligand donor to protein accep-
tor interactions in blue sticks, and Coulombic interactions in half gray 
and half red/blue/yellow sticks); experimentally determined ligand 
poses to the SHBG binding pocket (middle, PDB Codes 1D2S and 
1LHU); and QuanSA predicted alternative poses for estradiol (right).
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uncorrelated, so the combined predictions were synergistic 
with respect to accuracy.
As the difficulty of predictions increased (measured by 
the similarity of predicted molecules to those available for 
training) so did deviations from experimentally determined 
activities. For the easiest cases, where differences of just 
a few atoms distinguished the test and training molecules, 
mean absolute error (MAE) was roughly 0.5 pKd units (0.7 
kcal/mol). For challenging cases by conventional QSAR 
standards, typical errors on blind test molecules were about 
0.7 log units (0.9 kcal/mol). In cases where it was possi-
ble to test QuanSA models on large sets of ChEMBL data, 
typical errors were higher, ranging from 0.9–1.5 log units 
(1.2–2.0 kcal/mol), but the models were able to identify 
potent and structurally novel molecules with high specificity 
and produced highly statistically significant rank orderings 
of potency.
QuanSA is implemented as a new module within the Sur-
flex Platform, first released with Version 4.2.
Methods, data, and computational protocols
The QuanSA approach is built upon the morphological 
similarity method that underlies Surflex-Sim [30] and also 
upon the QMOD method, particularly benefiting from more 
recent refinements [27]. Here, we will describe the algorith-
mic details, followed by the molecular data sets, and finally 
the computational procedures.
QuanSA response functions
Recall that the QMOD approach constructs a binding site 
model by choosing a set of small molecular fragments 
(“probes”) and refining their positions (a “pocketmol”). The 
procedure is carried out such that the intermolecular docking 
score between a ligand and the pocketmol [34], when opti-
mized for both alignment and conformation, will be close to 
the experimentally determined activity (units of pKd ). The 
physical effect of the probes that make up the pocketmol is 
made through the docking scoring function, whose positive 
interactions are principally composed of Gaussian steric and 
polar terms (the latter with a directional aspect) and whose 
negative interactions are dominated by a quadratic inter-
penetration penalty [35] as well as weaker sigmoidal and 
Gaussian penalties (for interpenetration and polar repulsion, 
respectively). So, the pocketmol, while being represented 
as molecular fragments, is actually producing a functional 
scoring field whose behavior is controlled by the precise 
composition of the pocketmol.
However, in the QMOD approach, a molecular fragment is 
either present or absent, with no weighting. This limits the pos-
sibility for representing certain aspects of protein flexibility. 
For example, a valine sidechain may have multiple orientations 
of very similar energy, where a ligand can make a favorable 
contact in one case using a small substituent but clash with the 
protein using a larger substituent unless the valine assumes a 
different orientation. In such a case, placement of a probe to 
mimic the position of the valine that is favorable to the small 
ligand substituent automatically precludes the larger one. 
Similarly, there are many cases where a protein hydroxyl may 
adopt multiple orientations, making it possible for a ligand to 
favorably present either a donor or an acceptor in very similar 
positions.
Situations such as these present problems for QMOD, and 
this is fundamentally an issue of inductive bias in the method. 
Within the QMOD formalism, because it makes use of molec-
ular fragments to model pocket interactions, the presence of a 
favorable steric interaction carries with it an assumption about 
its magnitude and a necessary hard constraint in interpenetra-
tion (these values come from the Surflex-Dock scoring func-
tion). Similarly, the presence of a favorable polar interaction 
with a ligand donor carries with it the assumption that a ligand 
acceptor would be unfavorable. For the QuanSA approach, it 
was possible to make different choices regarding the induc-
tive bias that is represented by the functional response terms 
so that they would be more congruent with flexible protein 
binding pockets.
Steric shape and hydrogen‑bond terms
The QuanSA approach is capable of representing the inter-
action types that QMOD constructs, but it is also capable 
of representing interactions that can easily capture protein 
pocket movement. As seen from Fig. 3, the response functions 
of QuanSA are Gaussian and sigmoidal in nature, following 
Eqs. 1 and 2: 
For a ligand in a given pose ( Lp ), at a particular observer 
point i, given the minimum distance to the molecular sur-
face ri , the hydrophobic/steric term is governed by the three 
learned parameters zS
i
 , 휇S
i
 , and pS
i
:
here c1 = 1 (the width of the Gaussian), c2 = 2 (affecting 
the degree of interpenetration allowed without penalty), and 
c3 = 1∕2 (the steepness of the sigmoidal term). The three 
learned parameters are constrained to be non-negative for 
this term, which can also be thought of as a shape term. Note 
(1)g(x, 휎) = e−x2∕휎
(2)s(x, 훼) = 1
1 + e−x∕훼
(3)di = ri − 휇Si
(4)Si = zSi ⋅ g(di, c1) − pSi ⋅ s((di + c2), c3)
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that all of the response terms are dependent on the ligand 
pose, but Lp is omitted for clarity.
At a particular observer point i, given the minimum dis-
tance to a hydrogen-bond donor, denoted rD
i
 , the corresponding 
term is governed by the learned parameters zD
i
 , and 휇D
i
 (with 
c4 = 1∕2 , affecting the width of the Gaussian):
The two learned parameters are constrained to be non-neg-
ative for the hydrogen-bonding terms. The MD
i
 value (direc-
tional magnitude) is determined by the directional corre-
spondence between the donor or acceptor and the observer 
point location, possibly scaled upward by formal charge, as 
detailed previously in the definition of the morphological 
similarity function [30]. The hydrogen-bond acceptor term 
A is defined analogously:
Figure 5 depicts typical examples of learned shape and hydro-
gen-bond donor terms, shown with ideal surface distances 
from the observer point of 2.0Å. In the case of the shape 
term, the favorable interaction magnitude can vary from zero 
to typically less than 0.5 pKd units. The unfavorable interac-
tion magnitude, which occurs at closer than ideal distances 
between observer point and molecular surface, can be zero 
but its typical range is larger than for the magnitude of the 
Gaussian portion. In sharp contrast to the QMOD approach, 
it is possible to learn subtle differences in these magnitudes as 
well as to model a “wall” in a pocket that carries no favorable 
interaction possibilities (blue line). These different qualita-
tive types of response functions (and varying magnitudes) are 
all possible within protein binding pockets when considering 
flexibility and the energetic costs of movement.
Similarly, for the hydrogen-bond interaction terms, QuanSA 
can learn differing magnitudes for the value of H-bond inter-
actions as well as either/or behavior from the perspective of a 
single observer point. Typical ranges for the z values of these 
terms are 0.0–1.0, as seen in Fig. 5. The directional aspect of 
the calculation is important. If, for example, a donor proton is 
oriented such that the X-H–Observer angle is 120◦ rather than 
the ideal 180◦ the strength of the interaction is reduced by half.
Coulombic effects
A sharp departure from the QMOD approach is the direct 
measurement of electric field effects from the estimated par-
tial charges at the atomic centers of the ligand (the charges are 
estimated as described in [28], closely related to the electron-
egativity equalization approach introduced by Gilson [36]). At 
each observer point, the potential energy of a point charge of 
0.2e (moved from an infinite distance to the observer’s loca-
tion) is calculated, with r ij denoting the distance from observer 
i to atom j and the partial charge of atom j being qj , as follows:
(5)Di = zDi ⋅ g(rDi − 휇Di , c4) ×MDi
(6)Ai = zAi ⋅ g(rAi − 휇Ai , c4) ×MAi
(7)휖(x) =
1
1 − s(x + c5, c6)
(8)Ei =
n∑
j=1
qjc7
휖(rij)(rij + 훿)
Fig. 5  Typical response functions for steric and polar terms are very 
similar in effect to the scoring function of Surflex-Dock.
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The units of Ei are in kcal/mol (with c7 = 332.0716 ). The 
definition of the dielectric, with c5 = 4 and c6 = 1∕2 , 
produces a value of 1 at close distances, and it begins to 
increase at a distance of approximately one water shell, then 
it increases without bound becoming effectively infinite at 
interatomic center distances of 6.0Å or more. By defining 
the Coulombic feature values Ei in this manner, they meas-
ure local electrostatic effects primarily, and they have a com-
putationally convenient cutoff that allows skipping of ligand 
atoms above a threshold distance. The Coulombic response 
terms ( Ci ) are defined as functions of Ei , controlled by two 
learned parameters per observer point, zC
i
 and 휇C
i
:
The 휇C
i
 values can be thought of as charge preference inflec-
tion points. With 휇C
i
= 0 and zC
i
> 0 , when Ei is positive, 
then Ci will be as well. As 휇Ci  increases, a larger positive 
value of Ei is required to produce a positive value of Ci . 
Here, c8 = 1.0 , which produces a gentle slope of response 
to changes in the electrostatic field.
Neither of the two learned Coulombic parameters are 
constrained as to sign, and the learned response curves can 
represent numerous different cases, as illustrated in Fig. 6. 
The upper left plot shows the simplest case conceptually, 
where a positive charge moving near an observer point is 
favorable (purple, green, and light blue curves), with larger 
effects at further distances as charge magnitude increases. 
The converse is true for negative charges. This corresponds 
to the situation where a formal negative charge sits at the 
bottom of a hydrophobic well, for example in a trypsin-like 
serine protease S1 pocket.
At the top right of Fig. 6, we see the case where a posi-
tive charge is preferred, but where the difference between a 
neutral or negative charge is minimal. Such cases can occur 
when, for example, a mobile protein carboxylate can shift 
to make a favorable interaction with a positive ligand charge 
in a particular location, but where the ligand remains well-
solvated if the ligand has insufficient positive charge in that 
location. A related case can occur where a negative charge 
is unfavorable but neutral or positive are equally accept-
able (bottom right). By flipping the sign of zC
i
 , the converse 
response curves result: symmetric preference for negative 
charge, “prefer negative,” and “dislike positive.”
A hydrophobic concavity will tend to trap water mol-
ecules, and displacement of the water can be quite favora-
ble in terms of free energy. This displacement is not easily 
modeled using Coulombic electrostatics (the magnitudes of 
the charges on the ideal ligand are small). This case can be 
learned by the QuanSA approach by two adjacent observer 
points, where one learns “dislike positive” and the other 
learns “dislike negative” (shown at bottom left of Fig. 6). 
In such a case, small local charges of either polarity are 
preferred in proximity to the observer point pair (light and 
(9)Ci = zCi ⋅ (s(Ei − 휇Ci , c8) − 1∕2)
dark blue lines), with increasing unfavorability as charge 
increases (green/yellow and orange/purple curves).
Overall QuanSA function
The overall predicted score P for a molecule in a particular 
ligand pose Lp is given as follows:
Recall that the individual response terms are each depend-
ent on the particular ligand pose Lp , as is the strain value 
(described in detail below). The optimal pose for a ligand is 
that which maximizes P.
Figure 7 illustrates the learned response function values 
for the entire set of 98 BZR molecules in their final opti-
mal poses at each of the 118 observer points (small dots 
colored orange for Coulombic response, green for steric, red 
for acceptor, and blue for donor). At top left, the response 
values are highlighted using larger dots for four different 
observer points, each having learned a key feature of activ-
ity. The large-amplitude orange sigmoid (one large dot for 
each training molecule) has learned a preference for negative 
charge, with its response inflection very close to zero charge 
(similar to the top left of Fig. 6).
Four particular points are circled, each corresponding to 
the particular value for the final optimal poses of training 
molecule meclonazepam. At right, large dots (118 for each 
of the four flavors of response function) represent the full 
set of values obtained by this pose. Each of the four circled 
values are close to the highest obtainable ones, and they cor-
respond to the locations shown in the molecular projections 
shown below the plots.
At the bottom left is a depiction of the learned pocket 
field z and p values. Steric response function magnitudes are 
shown with half green and half purple sticks, with the length 
of the green portion reflecting zS
i
 and the length of the purple 
portion reflecting pS
i
 . The red and blue sticks, respectively, 
represent receptor-side acceptors and donors, each seeking 
ligand-side complementation, with their lengths determined 
by zD
i
 (favorable to ligand donor) and zA
i
 (favorable to ligand 
acceptor). Sticks that are half-green and half red or blue (e.g. 
those near the orange circle) correspond to the magnitude of 
the Coulombic zC
i
 learned parameters. At the bottom right 
are atom-centric sticks, which integrate over the pocket-
field’s interactions with the ligand. Note that final final opti-
mal pose of meclonazepam (cyan carbons) is shifted from 
the initial pose (gray carbons) due to the optimization of 
molecular pose subject to the pocket-field and ligand strain.
The overall pocket-field function reflects a simple sum 
over geometrically interpretable local observations of a 
ligand taken from the fixed reference frame of the observer 
(10)P(Lp) =
n∑
i=1
(Si + Di + Ai + Ci) + strain(Lp)
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points plus a force-field based estimate of ligand strain (see 
Eq. 10). Because the response functions are non-linear, and 
because the score for a ligand is defined to be its maximum 
value over all possible poses, the pocket-field can represent 
complex phenomena such as size exclusion that lead to non-
additivity of functional group contributions [21, 22].
Observer point placement
The molecular alignment procedure (described next) pro-
duces potentially several alternative solutions, which con-
sist of an ideal pose for each training molecule along with 
potentially many related alternative poses (see Fig. 2). As 
Fig. 6  The response functions for the electric field of the ligand can be quite complex, offering the ability to learn common physical interactions 
in protein-ligand complexes that include protein movement and the presence of complex entropic and water effects.
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discussed above, the steric, donor, and acceptor observa-
tions are not overly sensitive to precise placement, but the 
Coulombic observations have a narrow range of distances 
in which they are properly responsive to changes in a mol-
ecule’s local electrostatic character. Because of this, the 
placement of observation points is made such Fig. that it is 
very likely that an observer exists within roughly 2–4Å of 
every part of the surface of any ligand that is in a reason-
able pose. However, both to reduce the chance of overfit-
ting and to reduce the computational expense, some care 
is taken to produce a small set of such points rather than 
simply producing everything within a rectangular grid hav-
ing 2.0Å spacing.
Fig. 7  The learned response functions for each type of molecular fea-
ture at each observer point reflect the sigmoidal and Gaussian shapes 
of the underlying functional forms; bolded plot points (upper left) 
correspond to all observed values for one response function each for 
four observers over all training molecules; bolded plot points (upper 
right) correspond to all observer values for every response function 
for only meclonazepam; and the colored circles indicate the particular 
highlighted observers in the plots and the 3D depictions (bottom).
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An initial set of observation points is placed by first con-
sidering the optimal clique (one pose per training molecule) 
as the union of all constituent atoms. A sphere is placed with 
its center at the centroid of the clique, with its radius being 
8.0Å beyond the furthest atomic surface point. This sphere 
is tessellated such that the inter-point distance close to 8.0Å. 
Each point is then moved as follows: 1) the minimum dis-
tance to the clique is calculated; 2) the point is moved toward 
(or away) from the centroid in order to make the minimum 
surface distance 2.0Å (so if the initial minimum distance is 
10.0Å, the point will be moved 8.0Å toward the centroid); 
and 3) the process is repeated a total of ten times. This pro-
cedure very rapidly converges on a set of points, each of 
which is nearly exactly 2.0Å from the nearest atomic surface 
of the clique.
However, given a mixture of small and large molecules, 
it may be that some of the smaller ones are “hidden” by the 
larger ones and therefore do not have an observation point 
nearby. So, the process is repeated, but rather than using the 
merged set of all training ligands, each training ligand is 
processed individually. If any of the ligand-specific observer 
points is greater than 2.0Å away from the evolving set, it is 
added to the set.
The resulting observation point sets form the locations 
from which the feature values are computed that drive the 
QuanSA response functions. For the BZR case, the proce-
dure results in 118 points, and for the steroid case, it results 
in 58.
Initial ligand alignment
One of the most challenging aspects of fully automatic 
purely ligand-based 3D-QSAR is the problem of multiple 
ligand alignment. A key finding from our work on exploit-
ing protein structures within QMOD to build better models 
was that the effect of greater fidelity in the initial ligand 
alignments had a much greater impact than specific details 
about the protein structures themselves [26]. While in a 
number of cases, de novo models have yielded solutions that 
are congruent with known binding sites [24, 25, 27], this 
is not always the case and, in general, depends on having 
multiple chemical series available during model-building. 
Here, we will briefly describe the more general QuanSA 
approach, which is built upon our prior work [24, 30, 37, 
38]. A detailed study that includes results on larger bench-
mark sets for multiple ligand alignment is planned.
The QMOD implementation relied on a user to make 
a selection of two to four training ligands from which to 
develop an alignment hypothesis, against which all other 
training ligands were aligned. This choice could have a large 
effect on prediction quality, and the alignment procedure, 
by relying on a small number of molecules to guide the 
remainder, is limited in the degree to which it can produce 
an overall set of initial ligand alignments that will account 
for all of the molecular variation that may be present.
We have shown that one aspect of model-selection that 
is predictive of future performance is model parsimony. 
High-parsimony models are those for which pairs of training 
ligands that have similar activity levels also share high shape 
and electrostatic similarity in their optimal final poses, just 
as we see in the steroid example. We have incorporated the 
parsimony concept into the multiple alignment algorithm, 
making use of a clique score that strongly weights the sim-
ilarity of pairs of molecules whose activities are similar: 
wij = g((pK
i
d
− pK
j
d
), 2) . So, if a pair of molecules has activ-
ity values differing by 0.5 pKd , the weight is 0.9, falling to 
0.6 at a 1 log difference, and to 0.1 at 2 logs difference.
All-by-all mutual optimizations of flexible ligands 
become intractable quickly, but structure-activity data usu-
ally consists of many exemplars from discrete chemical 
series. So, mutual alignments are built incrementally from 
a core set of automatically chosen diverse exemplars. The 
procedure is as follows:
1. All N training molecules are subjected to thorough con-
formational search [28].
2. The M most different ligands are selected (using normal-
ized 2D molecular similarity values [39]) from among 
the most active examples of the N training ligands. This 
is done as previously described with molecular diver-
sity computations [40, 41]. The default value of M is 
5, which is often enough to allow for thorough mutual 
similarity clique generation.
3. Given the M diverse ligands, each is flexibly aligned 
with each conformation of all others. The top scoring 
alignments are stored. Mutually similar core cliques of 
mutual alignments of M molecules are constructed by 
traversing through these pairwise alignments. All such 
cliques are scored based on pairwise similarity values 
weighted as described above, with the best such solu-
tions being retained (and with redundancy removed 
based on RMSD). The default number of maximal of 
such cliques is 7, but fewer may be generated in the case 
of redundancy.
4. The best cliques of M ligands are completed by flex-
ible alignment of the remaining (N-M) ligands (as well 
as generating additional alternatives for the M core 
ligands). Each of the molecules is aligned to each of the 
M conformers within the core clique, with the highest 
scoring poses being retained in a pose pool.
5. Each of the cliques now contains multiple poses for 
each of the full set of N training ligands. Using a greedy 
procedure, full near-optimal cliques of N poses are con-
structed incrementally. Given the final full N-molecule 
cliques, the pose pools are pruned such that no pose 
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for any training ligand is excessively dissimilar from its 
optimal pose.
6. The final cliques along with their associated pose pools 
are sorted according to score, with each forming a pos-
sible alternative starting point for the QuanSA learning 
procedure.
This procedure automatically addresses the problem of 
ligand selection for core initial alignment construction as 
well as that of making use of the maximal context of data 
from many training ligands. Because full cliques are con-
structed greedily, newly added molecules are able to help 
guide the pose choices for later ones. Figure 2 shows the 
full 20-molecule clique for the steroid SHBG case along 
with the alternative poses for a particular molecule. Note 
that the alternative poses include ones with very high devia-
tions in terms of RMSD from the optimal single pose, but 
that all poses are similar to one another in a 3D surface and 
electrostatic sense.
It is possible for a user to incorporate knowledge of the 
binding modes of some number of training ligands, by pro-
viding specific pose alternatives at the beginning of the 
procedure. It is also possible to specify constraints on the 
conformation of molecular subfragments or on the absolute 
position of a common element among different ligands. Such 
constraints are incorporated through the use of real-valued 
quadratic penalties imposed on deviations in dihedral angles 
or on specific atomic positions. In the work presented here, 
crystallographic docking-based guidance was used in two 
cases (AchE and thrombin), but no direct constraints on con-
formation or alignment were used.
For the steroid SHBG case (Fig. 2), the entire automated 
alignment process required less than 10 minutes.
Parameter initialization and refinement
The preceding has described the response functions of 
QuanSA, the placement of observer points, and the genera-
tion of initial molecular alignments. Each observer point 
has nine associated learned parameters: zS,A,D,C
i
 , 휇S,A,D,C
i
 , and 
pS
i
 . QuanSA makes use of a parameter fitting regime that is 
biased toward finding a final optimal set of parameters such 
that the final optimal training ligand poses will be relatively 
close to the initial optimal clique.
This is driven primarily by the initialization procedure for 
the learned parameters, which considers the single initially 
optimal pose for each training molecule:
1. The values for 휇S
i
 are set to be the average steric dis-
tances to the ligands within the top window activity 
(default 3.0 log units).
2. The values for zS
i
 are increased uniformly from 0.0 until 
the minimum mean-squared-error between experimental 
and calculated activities (MSE) is achieved. The optimal 
value is stored, and zS
i
 are set to zero.
3. Initial values for 휇D
i
 are set as with 휇S
i
 . Initial values 
for 휇A
i
 and 휇D
i
 are set in a similar manner, but the cal-
culation also takes into account the directional mag-
nitudes for the donors and acceptors (those with poor 
directional congruence to a particular observer point 
contribute little).
4. The values of zD
i
 and zA
i
 are adjusted in a similar manner 
as with zS
i
 , simultaneously, again to minimize MSE.
5. The values of zS
i
 , zD
i
 , and zA
i
 are all set to half of their 
optimal values, producing an average model halfway 
between the steric-only one and the donor-acceptor-only 
one.
6. The values of all learned parameters (including the 
Coulombic ones) are then optimized using a gradient-
directed line search, but the poses remain fixed to the 
initial optimal poses produced by the alignment proce-
dure.
7. Finally, the values for all learned parameters are further 
optimized by gradient-directed line search. But now 
each pose for each molecule is considered, and the pose 
with maximal score defines the live pose for each train-
ing ligand.
This entire process takes very little time, just seconds for the 
steroid SHBG case. For this case, the mean absolute error 
(referred to as MAE or “mean error” in what follows) for the 
model with optimal uniform values of zS
i
 (Step 2) was 0.9 log 
units. For the model with donor-acceptor-only uniform zD,A
i
 
values, mean error was 3.0 log units (reflecting the critical 
importance of hydrophobic shape in this case). The naively 
mixed 50/50 model (Step 5) produced an mean error of 1.7 
log units. Line search with fixed poses (Step 6) produced 
mean error of 0.2 log units. Finally, in Step 7, allowing for 
model-based pose choice, the mean error dropped to 0.1 
log units.
At this stage, a model is often quite accurate within the 
scope of the poses in the initial pose pool. However, when 
the model is applied, especially to molecules that diverge 
from the training set, one must optimize the poses of new 
molecules to the pocket-field that the model represents. Con-
sequently, a final stage of model refinement is carried out, 
where iterations of model refinement are interleaved with 
full Cartesian pose optimization for all training ligands (sub-
ject to a strain calculation using the MMFF94sf forcefield).
In the steroid SHBG case, the mean error for the training 
ligands using the complete initial pose set was 0.1 log units. 
However, when the ligands are allowed to find optimal con-
figurations, the mean error increases to 0.6 log units. In this 
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simple case, a single iteration of parameter refinement pro-
duced a convergent solutions, with MSE of 0.03 and mean 
error of 0.2 log units. The entire parameter refinement pro-
cedure required just over 1 minute.
Ligand strain
Ligand strain is important from two perspectives. First, 
clearly, highly strained ligand conformations should face 
some degree of penalty relative to less strained conforma-
tions when fit into a pocket-field in order to enhance pre-
dictive power as well as model specificity. Second, predic-
tions of bound ligand poses that deviate strongly from what 
a trained computational or medicinal chemist knows to be 
reasonable conformations reduce confidence in a model.
From our recent work on the ForceGen method [28], we 
established that using the most thorough conformational 
sampling setting (-pquant, recommended for QuanSA), for 
non-macrocyclic ligands, a close-to-crystallographic solu-
tion ( ≤ 1.25Å RMSD) is produced over 95% of the time. 
Initial conformer pools are restricted to 10 kcal/mol by 
default. Within the QuanSA scoring process, the global 
minimum that was uncovered by the thorough ForceGen 
search serves as a baseline. Deviations from this baseline 
energy (according to MMFF94sf) are weighted by a factor 
of 0.5. For example, a 1.0 kcal/mol deviation above baseline 
will result in the QuanSA score being reduced by 0.5 pKd 
units. This is just slightly lower than the normal conversion 
factor between units of pKd and kcal/mol.
Prediction quality metrics
One critical aspect in contemplating predictions from any 
machine-learning method for binding affinity is that of the 
domain of applicability. A particular set of training mol-
ecules can only provide information on parts of a binding 
pocket where ligands have exhibited variation, both based 
on shape and electrostatic properties. QuanSA provides 
four semi-orthogonal measurements for each prediction: 1) 
novelty, 2) confidence, 3) envelope violation, and 4) raw 
nearest-neighbor similarity. The first three are probabilisti-
cally normalized values based on analysis of variation within 
the training set.
The normalization process makes it possible to compare 
different values between test molecules (and among different 
models). For example, for the confidence value, at the end of 
training, each molecule in its final optimal pose is compared 
to all other training molecules, and the maximally similar 
one is identified. The set of maximal similarities is used to 
estimate the parameters of a normal distribution, so that new 
molecules can be compared with the degree of variation seen 
in the training set. Where structural variability in a training 
set is low, a particular similarity score will be converted into 
a lower normalized confidence value than when the struc-
tural varaibility is high.
Novelty measures the degree to which a new molecule 
exhibits features that were covered by the full set of all train-
ing data (calculated based on distributions estimated from 
the training molecules). Envelope violation measures the 
extent to which a molecule protrudes from the envelope 
explored by the training set (see [27] for additional details 
on the envelop penetration computation). The raw similarity 
value is useful in cases where very limited structural varia-
tion exists in the training set.
Molecular data sets
The results in this work were derived from the data sum-
marized in Table 1. Each of these has either been a centrally 
important QSAR benchmark (e.g. the steroid and 5-HT1a 
sets), a challenging independently curated benchmark (the 
Sutherland Set, consisting of the GABAA (aka “BZR”), 
COX2, AchE, and thrombin cases), one that allows for direct 
comparison to a physics-based approach (the FEP Set), or a 
data set that offers particular insight into the application of 
ligand-based binding site modeling to medicinal chemistry 
lead optimization (the muscarinic set).
Together, the eight data sets cover a broad space in terms 
of target types, and they also cover a long history in 3D 
Table 1  Summary of molecular datasets and their relative complexity.
Set name Benchmark source N train N blind test N ChEMBL test
Steroid globulins [1, 29, 32] CoMFA/compass 21 (CBG), 21 (SHBG) 10, 61 –
5-HT1a receptor [23, 31] Compass/QMOD 20 35 –
FEP benchmark [18] FEP 199 (eight targets) – –
GABAA receptor [4, 27] CMF/QMOD 98 49 1158
COX2 [4, 27] CMF/QMOD 188 94 2308
AchE [4, 27] CMF/QMOD 74 37 2436
Thrombin [4, 27] CMF/QMOD 59 29 2947
Muscarinic receptor [21] Pharmacia Med. Chem. 43 (refine: +26) – 993
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QSAR. With the exception of the muscarinic set, the data 
sets are described in some detail in the respective references 
in Table 1. The muscarinic set is analyzed in much more 
detail here than in prior work with QMOD [24]. The num-
bering scheme for the muscarinic antagonists used here was 
taken from the original reports, with series A numbering 
from Johansson et al. [42] and series B from Nordvall et al. 
[43].
Computational procedures
The results reported here were generated using version 
4.207 of the Tools and QuanSA modules of the Surflex 
Platform (the Docking module was also used in two cases). 
Ligand preparation was carried out as follows: 
sf-tools -pquant forcegen TrainList Mols/pq
--> Mols/pq-list
Mols/pq-*.mol2
 This produced up to 1000 conformers for each training 
ligand (though typically far fewer), Details on the ForceGen 
methodology are presented in [28].
Initialization and model building was carried out as 
follows: 
sf-quansa init TrainData TrainList qm
--> qm0[0-4]-clique.mol2
qm0[0-4]-init.mol2
 The TrainData file contains activity information (e.g. 
mol-m4a = 10.0, and the TrainList file contains pathnames 
to conformer ensembles from the ligand preparation step 
(e.g. Mols/pq-mol-m4a.mol2. For small and relatively rigid 
ligand sets (steroid, serotonin, BZR, and COX2 cases), the 
option -clrms 0.5 was specified in order to produce addi-
tional initial alignment alternatives. For thrombin and AchE, 
poses derived from docking were used to guide the produc-
tion of the initial ligand alignments: 
sf-quansa -clgiven givenposes.mol2
init TrainData TrainList qm
--> qm0[0-4]-clique.mol2
qm0[0-4]-init.mol2
 Model building was carried out for the top five align-
ments produced by the initialization procedure. Two 
methods were used to aid in model selection, one which 
combined information from model induction (including 
parsimony quantification) and one where a cross-validation 
procedure was used: 
sf-quansa build qm-init00 qm00
...
sf-quansa build qm-init04 qm04
--> qm0[0-4].qmp.mol2
qm0[0-4]-trainreport.txt
sf-quansa select ModelList qm
--> qm-selectreport.txt
sf-quansa xval qm-init00 qmxv00 5
...
sf-quansa xval qm-init04 qmxv00 5
--> qmxv0[0-4]-xvstats
 Choosing a model based either on the best scoring using 
the select procedure or using that with the lowest MAE from 
the cross-validation procedure made little difference in blind 
tests within the benchmark sets (the two methods frequently 
agreed). Here, preference was given to the selection proce-
dure that considered model parsimony.
For the muscarinic case, model refinement was car-
ried out, using the following procedure for refinement and 
scoring: 
sf-quansa add qm01 AddData AddList qm01ref
sf-quansa score qm01ref Chembl-List qm01reftestchembl
--> qm01reftestchembl-report.txt
 Additional details can be found in the data archive asso-
ciated with this study (see www.jainlab.org for details on 
obtaining the data or the software).
Results and discussion
Each of the data sets studied in the course of this work 
addressed different aspects of ligand-based binding affinity 
prediction. Results will be presented first on two sets of par-
ticular importance in the QSAR field [1, 31], then on mul-
tiple series that formed a validation benchmark for a recent 
implementation of a free-energy perturbation approach [18], 
then on four sets from a challenging QSAR benchmark [44]. 
Last, a series of muscarinic ligands is modeled, where the 
analysis is focused on the relevance of QuanSA to lead opti-
mization [21] and on the concordance of the induced model 
to the recently solved crystal structure [45]. QuanSA models 
were generated purely from SAR data for SHBG, 5-HT1aR, 
the FEP data set, BZR, COX2, and the muscarinic receptor. 
To demonstrate the feature of using protein structure infor-
mation during initial ligand alignment, the initial poses for 
AchE and thrombin were derived from docking.
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Steroid binding globulin and 5‑HT1a
R
 examples
One very common approach to model quality assessment 
in QSAR has been cross-validation (often leave-one-out). 
With the QuanSA approach, cross-validation is offered as 
one of two means to adjudicate between alternative models, 
typically models derived from different initial alignments. 
The other model selection approach uses model’s quantita-
tive parsimony along with the rank correlation and mean 
absolute error of the training ligands after having been re-fit 
to the pocket-field. For the CBG and SHBG cases, the latter 
approach identified the top-ranked alignments produced by 
the initialization procedure as being the preferred models. 
Figure 8 shows the results of a leave-one-out cross-valida-
tion for CBG and SHBG using the top-scoring initial align-
ment. In both cases, Pearson’s r2 was very high (0.77 and 
0.81, respectively). For context, the original CoMFA study, 
which introduced this benchmark, reported cross-validated 
r2 values of 0.66 and 0.55, respectively [46], and a very early 
Compass study reported 0.89 and 0.88 [32]. It is impor-
tant to understand that the 95% confidence intervals for the 
QuanSA r2 results, owing to the small set of 21 molecules, 
were 0.44–0.92 (CBG) and 0.66–0.92 (SHBG). So, none of 
these results are likely to represent a substantial difference 
in predictive quality.
Of course, cross-validation results are always less inter-
esting than results on blind predictions (for any application 
of any machine-learning method). This is especially true for 
methods to be applied in lead optimization, where we expect 
to identify or design molecules that are different enough in 
character from training molecules to have different popula-
tion characteristics [47]. Figure 9 depicts performance of 
the two QuanSA models on blind test sets consisting of 10 
molecules for CBG (from the original CoMFA study) and 61 
molecules from a much more recent study from Cherkasov 
et al. [29].
Based on prior work with QMOD, using the measures of 
prediction confidence described above, we adopted thresh-
olds of ≤ 0.85 for novelty, ≥ 0.35 for confidence, and ≤ 0.95 
for exclusion violations [27]. The conjunction of novelty 
and exclusion criteria form the broadest set of predictions 
that should generally be considered as likely to be accurate 
(termed “in-model”), and the conjunction of confidence and 
exclusion criteria usually produces a narrower set (termed 
Fig. 8  Leave-one-out cross-validation results for CBG and SHBG 
(lines indicate the 1 and 2 kcal/mol error boundaries).
Fig. 9  Blind prediction results for CBG and SHBG, with filled circles 
identifying in-model predictions.
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“high-confidence”) with more accurate predictions. Note, 
however, that for predictions near the highest range of the 
training data (or higher), error magnitudes are typically quite 
low, independent of the quality measurements.
The highlighted points (filled circles) in the plot corre-
spond to the set of high-confidence predictions. For CBG, 
the mean error for this set (just five molecules) was 0.2 log 
units, Kendall’s Tau (a non-parametric rank-correlation 
measure) was 1.0 (p < 0.05), and r2 was 0.82. The ten-
molecule CBG blind prediction set has been the subject of 
innumerable analysis, including particular discussion of an 
infamous fluoro-substituted outlier, where an H to F substi-
tution produces a 2.0 log unit decrease in pKd (molecules 
30 and 31 of the blind set). We believe that it should be 
incumbent on the prediction method itself to provide meas-
ures that allow for unbiased identification of the subset of 
molecule on which predictions should be believed. Further, 
prediction sets with just a handful of molecules are unhelpful 
in assessing model quality.
For the SHBG case, the blind test included 61 molecules, 
of which 27 were high-confidence (filled green circles in 
Fig. 9). For this set, the mean error was 0.5 log units, Ken-
dall’s Tau was 0.74 (p < 0.00001), and r2 was 0.67. The full 
set of 61 was sufficiently large and related enough to the 
training set (the mean raw similarity value was 0.90), that it 
is not unreasonable to consider prediction statistics overall: 
mean error 1.0, Tau 0.60 (p < 0.00001), and r2 was 0.47. 
While quantitative performance clearly was diminished, the 
results were still highly statistically significant.
Figure 9 shows two blind predictions from the set of 
61 diverse test ligands. The first (ChEMBL261407) met 
the confidence criterion but neither the exclusion nor nov-
elty criteria. However, it was predicted to be among the 
highest activity values from the training set. The second 
(ChEMBL265940) met both the confidence and exclusion 
criteria despite being a substituted benzofuran rather than a 
steroid at all.
Figure 10 shows the results for constructing a QuanSA 
pocket-field using 5-HT1a ligands. This set of 20 training 
ligands and 35 blind testing ligands was originally used in 
a validation exercise for Compass [33]. The training set is 
exemplified by molecules m4a and m8b, and the test set 
consisted of variations in the angular and linear tricyclic 
structures (including changes to the ring fusion chirality) as 
well as more substantially different examples such as mol-
ecules m45 and m46. The benchmark is particularly chal-
lenging because the primary driver of potency variation is 
the detailed shape of hydrophobic parts of the ligands, with 
small changes in chirality or changes of a few atoms result-
ing in significant effects on pKd . For example, the enanti-
omer of m4a has a pKd reduced by 1.5 log units, and the 
enantiomer of m8b has pKd < 6.0.
As seen in the plot, predictive performance was quite 
accurate, with most molecules (whether nominally in-model 
or not) being predicted within 1 kcal/mol and just a hand-
ful at or slightly beyond the 2 kcal/mol error level. For the 
22 in-model molecules, Tau was 0.74 (95% CI 0.52–0.91, 
p < 0.00001 ), MAE was 0.64 log units. For the full set of 35 
molecules, Tau was 0.58 (0.34–0.76, p < 0.00001 ) and MAE 
was 0.66. QMOD predictions for the full set of 35 resulted 
in a Tau of 0.34 ( p < 0.01 ) and MAE of 0.8 [23]. Compass 
predictions produced a Tau of 0.36 ( p < 0.01 ) and MAE 
of 0.8 [33]. The QuanSA predictions were clearly superior 
those from QMOD and appear to be significantly better than 
those from Compass.
The particular predictions shown in Fig. 10 on the novel 
scaffolds are not only quite accurate, but they appear to be 
correct for the right reasons. The pose optimization proce-
dure placed the protonated amines in close correspondence 
to the training ligands, fit the alkyl nitrogen substituents into 
the pocket established by the training examples, and allowed 
the carbonyl of the urea to mimic the acceptor interaction 
made by hydroxyl substituents in various training molecules.
The steroid and 5-HT1a benchmarks do not represent 
a comprehensive validation for any 3D-QSAR method. 
However, they represent a necessary condition. If a method 
Fig. 10  Training on 20 molecules, all with the canonical scaffolds 
shown above, produced a remarkably general model, as shown by a 
test of 35 molecules, including examples with very different scaffolds.
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cannot yield predictive models in these cases, where ligands 
are relatively small and rigid, and where molecular align-
ments are not enormously difficult, it is unlikely that more 
challenging cases of pharmaceutical relevance will prove 
to be tractable. Here, using fully automatic computational 
procedures, highly predictive models were produced with no 
requirement for manual ligand alignment.
Physics versus machine‑learning: comparison to FEP
As mentioned in the Introduction, there has been a resur-
gence in interest in practically applicable physics-based esti-
mation of binding free energy, exemplified by a recent study 
[18], where data presented for 199 compounds covering 
eight pharmaceutically relevant targets enables a comparison 
here. The FEP approach typically requires a single ligand 
with known free-energy of binding along with a correspond-
ing experimental structure of the ligand bound to the protein 
of interest. From this reference ligand, a set molecular trans-
formations can be made and arranged into a connected graph 
such that connected pairs of molecules have relatively high 
similarity. For each such connected pair, a calculation of the 
ΔΔGij is carried out. To obtain a prediction for a particular 
molecule k, one begins from a molecule with known ΔGexp 
and traverses a path of connected molecules, each time add-
ing the calculated difference in energy. Cycle-closure con-
straints are enforced such that traversal of different paths to 
a particular molecule will yield the same value of ΔGpred.
Because of the construction of the connected graph of 
molecular mutations, one may initiate the calculation of any 
molecule’s ΔGpred from any molecule whose experimental 
free-energy of binding is known. Figure 11 (left) shows the 
reported results for the FEP calculation in pKd units (top) 
for all eight targets. These results are for the case where 
the ΔGpred values are computed from the single reference 
compound for each of the eight targets (a realistic applica-
tion scenario).
The middle plot shows the results for QuanSA, where, 
for each target, five models were constructed, each with a 
non-overlapping 20% of the molecules reserved for blind 
scoring. No crystal structure information was used in any 
fashion. The pocket field models were induced using infor-
mation only from the ligand structures and their corre-
sponding activities. The collection of the five sets of blind 
predictions were used to assess performance. The FEP and 
QuanSA methods are essentially orthogonal in strategy, and 
Fig. 11  FEP calculated pKd using the specified target reference com-
pound from which to calculate pKd for other target ligands using indi-
vidual ΔΔGij calculations (left plot); QuanSA predicted pKd using 
purely ligand-based models (middle plot) constructed using 80% of 
the training data (repeated 5 times on non-overlapping splits), and the 
combined performance of the two approaches (right plot). Typical 
examples of FEP mutation pairs for three targets, with the left-hand 
compound in each case being the target’s reference ligand and the 
right-hand one having the largest change in experimental free energy 
of binding of those computed.
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their prediction errors are uncorrelated (data not shown). 
Consequently, the combination of the two, calculated by 
averaging each molecule’s two ΔGpred values, results in an 
improved overall set of predictions (rightmost plot).
The three molecular pairs are typical of the molecular 
changes for which FEP ΔΔG values are computed and also 
give an idea of the variation within each target data set. The 
prediction conditions in Fig. 11 represent realistic scenarios 
for each method. For FEP, a connected set of alternatives are 
predicted from a compound whose bound structure and free 
energy is known. For QuanSA, information from a collection 
of compounds is used to predict on a set a quarter as large as 
that used for training.
Both methods also have best-case scenarios, each of 
which is worth analyzing. In the original paper, the reported 
FEP ΔGpred were adjusted from what is shown in Fig. 11. 
Rather than calculating the nominal ΔGpred values based 
only on the known reference ligand’s ΔGexp , the predicted 
free-energy values were re-centered such that their mean 
would match the mean ΔGexp (the procedure is described 
in detail in the Supplemental Information for [18]). From a 
machine-learning perspective, this is spiritually similar to a 
leave-one-out validation experiment. For FEP, a cross-val-
idation without any information contamination would have 
required making use of (N − 1) true ΔGexp values to predict 
each “hold-out.” However, the mean estimated from (N − 1) 
ligands rather than N would not differ by much. The informa-
tion leak from using ΔGexp
i
 for a molecule in this fashion to 
calculate ΔGpred
i
 is negligible. Note also that this correction 
has no effect at all on within-target correlation statistics.
For QuanSA, the best-case calculation is a leave-one-out 
cross-validation that makes use of the reference ligand’s 
bound structure to guide the induced molecular alignments. 
By leaving a single compound out, maximal information is 
used to derived the pocket-field, and ensuring that the ligand 
conformations are reasonable close to the correct absolute 
configuration provides a minor bias in favor of physically 
correct models (though these ligands and variations are sim-
ple enough that this makes little difference).
Table 2 shows summary statistics for rank correlation 
and MAE for both the best-case and realistic application 
scenarios for both methods. Here, Kendall’s Tau was used, 
with resampling-based calculation of confidence intervals 
(a value of 0.2 pKd units defined tied experimental activ-
ity values). For FEP, the prediction re-centering procedure 
improved the overall MAE by just over 25%, but in indi-
vidual cases, the reduction in MAE was nearly 50%. For 
QuanSA, the MAE values are not substantially different, 
either per-target or overall. However, while the per-target 
correlation values have wide confidence intervals due to 
small sample sizes, the overall rank correlation perfor-
mance begins to show an edge for the best-case approach. 
Due to small sample sizes, it is difficult to make a strong 
case, but it appears that the FEP approach is likely better in 
the thrombin case and that the QuanSA approach is better 
in the CDK2 case.
The striking aspect of this comparison is not that one 
method is clearly better or worse than the other. Rather, it 
is that one method relies on direct simulation-based ener-
getic modeling of protein-ligand interactions, that another 
infers the protein-ligand interaction energy landscape from 
structure-activity data, and that both methods produce very 
similar results across eight diverse targets. Further, the can-
cellation effect of orthogonal errors is substantial. Table 3 
shows the rank correlation and MAE data derived by com-
bining the realistic-scenario FEP and QuanSA predictions. 
In all eight cases, the combined result is either better than, or 
extremely close to, the best result from either method alone.
Using a single standard Intel i7 computing core, the 
QuanSA scoring process, in its default thorough search 
Table 2  Results on the FEP test set of 199 molecules under two prediction regimes for FEP and QuanSA (units for MAE are pKd)
Tau using the FEP reference molecule ΔG is the same as the corrected predictions in all cases, except for when considering all molecules, where 
Tau was 0.63 (95% CI 0.57–0.68))
Target N FEP (corrected) FEP (ref ΔG) QuanSA LOO QuanSA 80/20 (fivefold)
Tau (95% CI) MAE ± 휎 MAE ± 휎 Tau (95% CI) MAE ± 휎 Tau (95% CI) MAE ± 휎
BACE 36 0.66 (0.48–0.80) 0.49 ± 0.40 0.90 ± 0.50 0.51 (0.24–0.74) 0.37 ± 0.33 0.57 (0.37–0.74) 0.35 ± 0.30
CDK2 16 0.29 (− 0.16–0.71) 0.65 ± 0.42 0.65 ± 0.43 0.82 (0.53–1.00) 0.38 ± 0.24 0.78 (0.57–0.96) 0.41 ± 0.24
JNK1 21 0.87 (0.69–0.99) 0.78 ± 0.33 1.30 ± 0.83 0.68 (0.47–0.87) 0.41 ± 0.31 0.70 (0.52–0.86) 0.48 ± 0.37
MCL1 42 0.64 (0.49–0.77) 0.62 ± 0.46 0.68 ± 0.53 0.64 (0.43–0.81) 0.39 ± 0.41 0.63 (0.39–0.81) 0.44 ± 0.48
p38 34 0.53 (0.34–0.68) 0.64 ± 0.33 0.71 ± 0.64 0.41 (0.21–0.58) 0.59 ± 0.37 0.32 (0.07–0.55) 0.66 ± 0.54
PTP1b 23 0.78 (0.50–0.96) 0.45 ± 0.40 0.74 ± 0.48 0.59 (0.33–0.81) 0.55 ± 0.58 0.49 (0.19–0.74) 0.82 ± 0.62
Thrombin 11 0.60 (− 0.05 to – 
1.00)
0.31 ± 0.26 0.50 ± 0.42 − 0.07 (− 0.89 to 
– 0.55)
0.39 ± 0.35 0.42 (− 0.25 to 
–0.74)
0.32 ± 0.28
Tyk2 16 0.80 (0.56–0.96) 0.33 ± 0.27 0.50 ± 0.44 0.72 (0.46–0.93) 0.44 ± 0.28 0.59 (0.28–0.87) 0.56 ± 0.43
All 199 0.68 (0.63–0.73) 0.56 ± 0.40 0.77 ± 0.59 0.72 (0.67–0.77) 0.45 ± 0.38 0.64 (0.57–0.71) 0.51 ± 0.46
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mode, required typically 20–40 seconds for molecules of 
the complexity represented by the FEP test set. By contrast, 
the FEP approach required approximately six hours per indi-
vidual perturbation calculation using eight NVIDIA GTX-
780 GPUs. As will be shown in what follows, QuanSA is 
suitable for large-scale calculations of thousands of synthetic 
alternatives, and it can be used to identify potent molecules 
with novel scaffolds. Where feasible, both computationally 
and in terms of theoretical applicability, methods such as 
FEP could be profitably employed to provide an orthogonal 
estimate of binding affinity.
More challenging predictions and application 
to ChEMBL data
The FEP set includes eight diverse protein targets, but the 
ligand diversity is limited. As seen in Fig. 11, relatively 
small modifications at discrete positions on a single scaf-
fold represented the typical range of structural variation. The 
3D-QSAR benchmark reported by Sutherland et al. [44] was 
designed to present a significant extrapolative challenge for 
methods, with designed test sets for each of eight targets. 
For each target, approximately one-third of molecules for 
were selected by optimization using a maximum dissimi-
larity algorithm and were assigned to the test set, with the 
remaining compounds assigned to the training set. For four 
of the eight targets (BZR, COX2, AchE, and thrombin), sub-
stantial ChEMBL data was available, and this was used to 
further test extrapolative ability for the QMOD approach 
[27]. Here, we reports results for the QuanSA approach on 
these four targets using both the original blind test data as 
well as the ChEMBL data.
Table 4 summarizes results for these four targets on the 
Sutherland test set, with results for QuanSA included on the 
in-model subset of compounds as well as the full test set. 
In all four cases, QuanSA yielded statistically significant 
predictions for both the in-model subset and the full blind 
test ( p < 0.001 for BZR, COX2, and AchE, and p < 0.01 for 
thrombin). The mean absolute error was in the range seen 
with FEP and QuanSA on the FEP Set under realistic pre-
diction scenarios (with QuanSA error values being slightly 
lower and FEP error values being slightly higher). However, 
the Kendall’s Tau values were slightly lower for these four 
targets from the Sutherland Set. This primarily reflects the 
greater jumps from knowns to unknowns in the data under-
lying Table 4.
Ideally, it would be useful if one could compare Tau and 
MAE values from different methods on various data sets. 
The problem with such comparisons is that some datasets 
are exceptionally challenging relative to others. The rela-
tive challenge of each data set for prediction is quantified in 
Fig. 12. The median nearest-neighbor similarity for test mol-
ecules for the targets within the original Sutherland bench-
mark (orange line) was 0.92, which was substantially more 
challenging than the FEP Set (yellow line). For the 80/20 
blind QuanSA validation for the FEP Set, 80% of the test 
molecules had nearest neighbor 3D similarities to training 
molecules of 0.93 or greater. For the Sutherland Set, fewer 
than 40% of the test molecules had nearest-neighbor simi-
larities of that magnitude. Just 1% of test molecules within 
the FEP Set had 3D nearest-neighbors with 0.85 3D similar-
ity or less, but the corresponding value for the Sutherland 
Set was 13%.
Table 5 shows summary statistics for the four Sutherland 
targets on ChEMBL data (and for the muscarinic acetyl-
choline receptor, discussed in the next section). The total 
number of test compounds ranged from 1000–3000, and 
the coverage with respect to in-model predictions varied 
considerably. For the thrombin case, the training set was so 
small (59 compounds) and so narrow (all inhibitors were 
meta-substituted benzamidines with minor variations at two 
Table 3  Results from combining the FEP (uncorrected reference 
compound ΔG ) predictions with the QuanSA 80/20 pure ligand-based 
predictions
Target Tau (95% CI) MAE ± 휎
BACE 0.72 (0.54–0.86) 0.46 ± 0.32
CDK2 0.74 (0.46–0.97) 0.41 ± 0.29
JNK1 0.78 (0.62–0.88) 0.73 ± 0.46
MCL1 0.70 (0.55–0.83) 0.44 ± 0.31
p38 0.55 (0.33–0.72) 0.49 ± 0.42
PTP1b 0.71 (0.42–0.91) 0.61 ± 0.44
Thrombin 0.47 (− 0.16 to 0.89) 0.30 ± 0.22
Tyk2 0.85 (0.69–1.00) 0.39 ± 0.31
All 0.72 (0.67–0.77) 0.49 ± 0.37
Table 4  Test results for the 
complete Sutherland benchmark QuanSA in-model QuanSA full test QMOD full test
% 휏 MAE r2 휏 MAE r2 휏 MAE r2
BZR 45 0.54 (0.36–0.72) 0.54 (0.38–0.74) 0.39 (0.15–0.69) 0.53 0.61 0.36 0.42 0.65 0.27
COX2 81 0.54 (0.41–0.66) 0.84 (0.67–1.04) 0.41 (0.24–0.57) 0.49 0.90 0.34 0.39 1.01 0.22
AchE 68 0.58 (0.30–0.80) 0.71 (0.51–0.95) 0.57 (0.23–0.84) 0.51 0.83 0.47 0.60 0.68 0.56
THR 66 0.51 (0.19–0.77) 0.69 (0.50–0.89) 0.51 (0.18–0.77) 0.45 0.89 0.29 0.51 0.69 0.42
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positions), that zero ChEMBL molecules met the criteria 
for being in-model. This case will not be discussed further.
For the other three cases, coverage ranged from roughly 
10% for BZR and AchE to 25% for COX2, which had the 
largest training set (188 molecules, more than twice as many 
as the other cases). In all three cases, Tau was very simi-
lar (roughly 0.25), corresponding to very small p-values 
( < 0.0001 ). MAE was roughly 1 log unit for BZR and COX2 
(less than 1.5 kcal/mol on average) and was higher for AchE 
(just over 2 kcal/mol).
Referring to Fig. 12, for ChEMBL predictions, the most 
similar in-model prediction set was for COX2 (blue line), 
with BZR being the most challenging (purple) and AchE 
falling in the middle (green). The AchE case presented 
additional difficulty due to the generally large and flexible 
ligands, which increase uncertainty with respect to pose and 
ligand energetics.
Figure 13 illustrates two in-model ChEMBL predictions 
along with their nearest training neighbors along with one 
prediction whose novelty value exceeded the threshold of 
0.85. The leftmost molecule was very accurately predicted, 
showing the introduction of a methyl-oxadiazole in place of 
the alkyl-ester that was well represented in the training data. 
From a medicinal chemistry point of view, this is an inter-
esting leap, though likely not terribly surprising for those 
experienced with common bioisosteric substitutions [48]. 
For reference, the nearest-neighbor similarity in this case 
was 0.92, matching the typical test molecule from within 
the Sutherland Set.
The canonical BZR ligands used to construct the QuanSA 
model were known from the early 1960’s (e.g. diazepam 
[49]), the early 1970’s (e.g. alprazolam [50]), and the early 
1980’s (e.g. compounds such as RO 15-3505 [51]). The 
middle molecule, representative of several well-predicted 
pyrazolo-pyridine esters, is a genuinely significant scaffold 
leap. The scaffold was first disclosed in 1989 [52] and was 
designed on the basis of a similar triazolopyridazine known 
from about a decade earlier. The rightmost molecule, a car-
boline derivative that is out-of-model, is representative of a 
class that was known contemporaneously with some of the 
Table 5  Results for QuanSA models on diverse ChEMBL com-
pounds, with N being the total number of tested compounds, “N i-m” 
being the number of in-model predictions, and the statistical perfor-
mance assessed by Kendall’s Tau and mean absolute error
Target N N i-m Tau (95% CI) MAE
BZR 1158 148 0.25 (0.12–0.37) 1.2
COX2 2308 549 0.24 (0.18–0.30) 1.0
AchE 2436 186 0.26 (0.16–0.35) 1.6
Thrombin 2949 0 – –
Muscarinic 993 291 0.34 (0.26–0.41) 1.1
Fig. 12  The relative difficulty of the molecules to be predicted varied 
considerably, as measured by the nearest-neighbor 3D similarity of 
the final predicted pose for each test molecule relative to the closest 
training molecule.
Fig. 13  Examples of extrapolation to ChEMBL molecules for the 
QuanSA BZR model. The left-most and middle molecules are both 
in-model predictions, and the right-most falls above the novelty 
threshold.
750 Journal of Computer-Aided Molecular Design (2018) 32:731–757
1 3
training molecules, but none were included in the training 
set.
These QuanSA predictions are significant for four rea-
sons. First, the GABAA receptor is a complex hetero-mul-
timeric ligand-gated ion channel, part of a large group of 
important pharmaceutical targets that are very challenging 
for biophysical characterization down to atomic resolu-
tion. The pocket-field was constructed automatically, using 
only ligand structure and activity information. Second, its 
prediction quality rivaled that seen for the FEP Set, where 
protein structures were known and where structural jumps 
were smaller. Third, because the method is relatively fast, 
application to thousands of candidates (using modest com-
puter hardware) is possible, allowing for evaluation of a 
large chemical design space, with built-in calculations for 
the applicable model prediction domain. Fourth, the method 
produced predictions of both pKd and bound pose, with the 
latter offering support for predictions that otherwise might 
be difficult to justify for experimental follow-up.
Figure 14 illustrates the AchE QuanSA pocket-field. The 
AchE enzyme pocket is a 20Å gorge, with key interactions 
being made by the labeled residues. In particular, Trp286, 
Tyr72, Asp74, and Tyr341 of the peripheral anionic site play 
a key role in the electrostatic attraction to cationic ligands. 
Tyr337 and Trp86 near the bottom of the gorge interact with 
the quaternary ammonium group of the substrate acetylcho-
line. The transparent surface shows the induced pocket-field, 
and the amine of training molecule 1-19 can be seen to have 
a strong interaction in the direction of the face of Trp-286 
(long blue stick). Lower down, the dual carbonyl atoms 
of the phthalimide linker make favorable interactions (red 
sticks) with both sides of the pocket (blue shaded area).
ChEMBL-95020 presents a convincing superimposition 
of the isoxazole-containing tricycle [53] to the phthalim-
ide of the training molecule. In a 2D sense, this prediction 
seems more surprising than the nominal 3D similarity value 
would suggest, but the actual disposition of chemical func-
tionality and its mimicry of known ligands makes this not 
only an in-model prediction but a confident one that is also 
accurate. The right-hand prediction [54] in Fig. 14 is also 
in-model, but it is of lower confidence and is more typical 
of the level of prediction error in the AchE ChEMBL set. 
Rather than making very similar polar interactions as the 
phthalimide, it fills the lower-left hydrophobic cavity of the 
pocket. However, the areas of correspondence between the 
novel ligand and in terms of pocket-field complementarity 
and relationship to other AchE ligands provides confidence 
in the prediction.
Many more examples of such extrapolative predictions 
exist, but rather than enumerate them, Table 6 provides sum-
mary statistics on true positive recovery rates and two differ-
ent estimates of false positive rates. Here, we have defined 
true positives as those molecules for which pKi ≥ 7.5 . For 
those molecules with measured activity, false positives 
were defined as those molecules for which pKi ≤ 6.5 . This 
is a strict test of the ability to distinguish relatively active 
molecules from those that are slightly less active, and it is 
relevant in contemplating the effectiveness of a prediction 
method for synthetic prioritization. We have also made use 
Fig. 14  Examples of extrapolation to ChEMBL molecules for the 
QuanSA AchE model.
Table 6  Test results for 
the complete Sutherland 
benchmark.
Target Full ChEMBL set QuanSA in-model pred. pKi ≥ 7.5 1000 Decoys
N pKi ≥ 7.5 pKi ≤ 6.5 N Mean pKi N TP TP % N FP FP % FP %
BZR 1158 309 544 90 6.9 38 12.3 32 5.9 1.1
COX2 2308 351 1488 169 7.2 90 25.6 49 3.3 0.0
AchE 2436 491 1437 36 7.6 24 4.9 14 1.0 0.0
Musc. 993 350 427 66 7.2 31 8.9 17 4.0 0.0
751Journal of Computer-Aided Molecular Design (2018) 32:731–757 
1 3
of a decoy set of 1000 drug/lead-like ZINC molecules, with 
the entire set presumptively defined as false positives. Con-
sidering the FP rate for the decoy set the value of a predictive 
method when evaluating very large numbers of candidates, 
possibly from a virtual screening library or a computational 
de novo design procedure.
For COX2, where we have not shown specific examples, 
the coverage of the ChEMBL molecules was highest (about 
25%), and the relative similarity of the in-model predictions 
to the training set was also high (see Fig. 12). This lead 
to a true-positive rate from the full ChEMBL set of 26%, 
so a model constructed from fewer than 200 COX2 inhibi-
tors (utilizing no protein structure) was able to identify a 
quarter of all of the potent COX2 inhibitors curated within 
ChEMBL, representing many years of discovery efforts. The 
enrichment rate was 8-fold (known actives to known inac-
tives). From the 1000 ZINC decoys, not a single molecule 
was identified as an in-model predicted true positive, sug-
gesting an enrichment rate in a screening scenario of well 
over 2000-fold. The situation for AchE was very similar, 
albeit with a lower true-positive rate 5%. Again, however, 
the model was very specific, with a 5-fold TP/FP enrichment 
between known actives and known inactives and not a single 
false-positive decoy identified.
The BZR case showed true-positive identification 
between that of AchE and COX2 (12%), but the false posi-
tive rate on the known inactive molecules was higher, lead-
ing to an enrichment of 2-fold. Similarly, application of the 
pocket-field to the decoy set identified 11 decoys, suggesting 
a screening-oriented false-positive rate of 1% and an enrich-
ment of just over 10-fold. It is not clear whether the BZR 
model is truly less accurate or less specific than the others, 
though this seems somewhat unlikely based on assessment 
of its quantitative predictive accuracy. It may be the case that 
the decoy set inadvertently contains a number of bona fide 
BZR ligands. The nominal nearest-neighbor similarities of 
the 11 nominal false-positives ranged from 0.67–0.90, which 
is within the range observed for the in-model ChEMBL pre-
dictions, but this is not definitive. It may also be the case that 
the BZR binding site is truly significantly more promiscuous 
than the other binding sites, but we have no direct evidence 
of this.
Summary of comparative performance
Two sets of comparisons to other methods have been carried 
out. The first set was to other QSAR methods on benchmarks 
of wide use or of particular significance to related methods. 
The second set was to FEP, a sophisticated physics-based 
simulation approach.
The QSAR comparisons included two steroid binding 
globulins [1, 32], 5-HT1a receptor, and four targets from a 
more recent benchmark [4, 44]. Considering the limitations 
of assay quality and of data set size, QuanSA performed as 
well or better than any reported method (including CoMFA 
and related methods and Compass) on the classic steroid 
cases, including accurate extrapolation to structurally novel 
molecules published 20 years after the introduction of the 
sets [29]. The 5-HT1a receptor case was the central valida-
tion example for the Compass method and was also used 
for validation of the initial QMOD approach [23, 33], and 
QuanSA performance was superior to either method. In the 
most challenging of the Sutherland cases (BZR and COX2), 
QuanSA results were substantially better than those seen 
with QMOD, whose performance exceeded that of CMF, 
CoMFA, and numerous 2D methods [4, 44].
With respect to the FEP comparison, individual chemical 
mutations across the entire set of eight targets resulted in 
errors of 0.9 kcal/mol for FEP [18]. For QuanSA, the compa-
rable situation was where 80% of the data was used to induce 
a purely ligand-based model to then predict the remaining 
20% of the data, and the result was a mean error that was 
slightly lower (0.7 kcal/mol). More importantly, though, was 
the observation that the errors made by the two methods 
were uncorrelated, so that combined predictions achieved 
robust predictive performance across all eight targets.
Explanatory power and correspondence with future 
crystallography
A particularly interesting aspect of drug-design for older tar-
gets that lacked biophysical characterization for many years 
is that chemical exploration was done agnostically, with the 
synthesized chemicals themselves being used to elucidate 
binding pockets. Consequently, exploration of positions on 
a particular scaffold were often driven by considerations of 
systematicity and synthetic feasibility.
The Compass method, an antecedent to QuanSA, was 
developed at Arris Pharmaceutical and was refined during 
a period of collaboration between Arris and Pharmacia in 
the early to middle 1990’s. This was a period during which 
Pharmacia was also pursuing muscarinic antagonists, result-
ing ultimately in the approval of tolterodine by the US FDA 
in 1998 (see Fig. 15). At the time, the potent anti-muscarinic 
QNB was commonly used as a radioligand for displacement 
assays, and oxybutynin was a competing muscarinic antago-
nist. Of course, atropine as a medicinal compound had been 
known for many decades, and it was established as a potent 
muscarinic antagonist in modern pharmacological assays 
by the 1950’s [55]. During this time-period two series of 
quinuclidinene anti-muscarinics were pursued by Pharmacia 
[42, 43].
Figure 15 depicts a QuanSA model-building and refine-
ment process that made use of a total of 43 training mol-
ecules (the four named molecules above plus 39 from two 
quinuclidinene series, with various substitutions on the furan 
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and benzofuran heterocycles and including variations such 
as thiophene and benzothiophene analogs). The process was 
completely automatic, using default parameters for ligand 
preparation, initial alignment generation, and model build-
ing. The model selection procedure identified the second-
ranked alignment clique of the top five as being likely to be 
most predictive. The resulting pocket-field was used to score 
1019 ChEMBL molecules, of which just 26 were nominally 
in-model. Given the poor coverage, these 26 molecules 
(actual pKi  ranging from 5.3–10.5) were used to refine the 
model.
Apart from statistics of quantitative accuracy, the value 
of a physical QSAR model derives in part from the degree to 
which it is making predictions for the right reasons. As with 
the steroid globulin case presented first, the decades have 
produced critical crystallographic information. In particular, 
PDB structure 3UON revealed the bound configuration of 
QNB bound to the human muscarinic acetylcholine receptor 
[45], which is the biological target that was being investi-
gated heavily roughly 20 years earlier. Figure 16 shows the 
protein binding pocket bound to QNB along with another 
antagonist-bound variant (rat M3, PDB Code 4U15). The 
crystallographic data was aligned to the muscarinic pocket-
field using the ligand QNB to minimize automorph-cor-
rected RMSD.
The predicted conformation of QNB (magenta, top mid-
dle of Fig. 16) was just 0.5Å RMSD from the bound form 
(green). The orientation of the amine was slightly off, and 
the orientation of the hydroxyl was significantly rotated 
away from the clear preference of the bound form. When 
bound, the hydroxyl proton interacts with the carbonyl of 
Asn-386. The predicted orientation is driven by energetic 
preferences of the ligand, turned toward the QNB’s ester 
carbonyl. This is similar to the problem of hydroxyl rotam-
ers seen in the steroid globulin case (Fig. 4). Very often, 
within a collection of SAR data, there will be no informa-
tion that allows for an unambiguous determination of the 
absolute conformations of the molecules. In such cases, 
this will become a problem when a molecule to be pre-
dicted would resolve the ambiguity but where the model 
has guessed incorrectly. Nonetheless, the 0.5Å deviation 
represents excellent agreement, given that QNB is a rea-
sonably flexible molecule.
The two quinuclidinene series shown in Fig. 16 were 
being optimized for potency, with the benzofuran scaf-
fold yielding no significant improvement over molecule b1 
(pKd = 7.2 ), despite extensive synthetic effort [42]. How-
ever, exploration of the furan scaffold yielded significant 
improvement (e.g. a49, with pKd = 7.9 , essentially equipo-
tent to tolterodine). Variations such as b29 (the analogous 
phenyl variant of the benzofuran scaffold to a49) represent 
particularly challenging data points to explain. Consider-
ing the 2D SAR, and assuming additivity, b29 should have 
been a significant improvement over b1 and a49, but it was 
essentially equipotent with b1.
To understand the reasons for the puzzling SAR, and to 
see whether the QuanSA approach would help explain it, 
we compared the results of docking (green sticks) to pre-
dicted pocket-field poses (magenta for a49 and cyan for b1 
and b29). For a49 (lower left), there was good agreement 
between the QuanSA-predicted binding mode and that from 
docking, though due to the rigidity of the molecule, the ori-
entation of the quinuclidinene was non-optimal in the dock-
ing. The 3-phenyl substituent fills the back of the pocket, and 
the furan oxygen points forward, making a favorable pocket-
field interaction. In the actual binding pocket, it appears to 
be a mobile tyrosine hydroxyl (clipped from the front of 
Fig. 15  Muscarinic model training, refinement, and scoring proce-
dure.
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the protein pocket depiction) that interacts with the furan 
oxygen.
Molecule b1, the unsubstituted benzofuran (cyan), orients 
its oxygen downward in order to optimize its pocket-field 
interaction, in direct conflict with the required orientation 
for a49 (magenta). Docking of b1 (not shown) resulted in 
many possible fits, all of which were inconsistent with the 
docked pose of a49, but some of which were close to the 
preferred QuanSA pose. For molecule b29, the anomalously 
less active phenyl benzofuran, the QuanSA-predicted pose 
(magenta, lower right), shifted the aromatic ring down from 
the preferred position of a49. The docking of b29 shifted the 
ring downward further, but in qualitative agreement with 
the model’s prediction. Here, there are clearly conflicting 
preferences for the phenyl substituent, the furan/benzofuran 
oxygen, and the hydrophobic portion of the benzofuran. The 
QuanSA model was able to induce a model of the binding 
pocket that quantitatively explained the activities and quali-
tatively explained the reason for the non-additive behavior.
Non-additive SAR is actually quite common, as pointed 
out by Klebe’s group [22]. Using detailed thermodynamic 
and crystallographic data involving thrombin inhibitors, 
they explicitly showed that a particular functional group 
change (-H to -NH2 ) exhibited context dependent ΔΔG 
effects. In cases where addition of the amino group created 
a “conflict-of-interest” with respect to the preferred bind-
ing mode of the sister molecule, the relative improvement 
of binding affinity was decreased. Strict additivity of func-
tional group contributions to binding should be expected 
only when the functional group modifications do not affect 
the conformation of the rest of the molecule or its overall 
alignment (and even in those cases may be affected by more 
subtle effects on free-energy such as differential enthalpy/
entropy compensation).
The initial, unrefined, pocket-field had a mean absolute 
error of 1.4 log units on the 26 in-model molecules, and the 
Kendall’s Tau of 0.19 missed a reasonable cutoff of statis-
tical significance ( p = 0.12 ). However, the refined model 
(constructed from a total of 69 muscarinic ligands) covered 
291 (29%) of the 993 remaining ChEMBL muscarinic set. 
The Kendall’s Tau rank correlation was 0.34 ( p < 10−6 ) and 
MAE was 1.1 log units (see Table 5). The model was also 
extremely specific in terms of decoy rejection (see Table 6), 
and it was comparable in quality for rejection of known inac-
tives to the COX2 model.
The overall true-positive identification of was 9%. This 
appears modest (a random selection of 66/993 would pro-
duce approximately double that number), but in the context 
of the false positive rates, the predictive value is clear. The 
QuanSA-driven procedure identified twice as many actives 
Fig. 16  The human M2 receptor bound to QNB aligned with rat 
M2 and the QuanSA predicted conformation of QNB (top left); the 
pocket-field and interactions with QNB (top middle); a striking exam-
ple of substituent effect non-additivity (top right); and the predicted 
poses by docking (a49 and b29, green) and QuanSA (a49 in magenta, 
and b1/b29 in cyan).
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as inactives from the ChEMBL set, despite the a priori prob-
ability being in the other direction. For the ZINC decoys, 
the random selection process would have yielded roughly 
70 false positives, but the QuanSA calculation produced 
zero. It would require much larger decoy sets to establish an 
accurate false positive rate in a screening sense, but based 
on the distributions of scores, novelty values, and exclusion 
values, it is likely to be less than 1/10,000, which suggest an 
enrichment rate of 1,000-fold or greater.
Figure  17 shows four examples of the predicted in-
model potent ChEMBL molecules. The first compound 
(ChEMBL-287868) was the most potent, but least inter-
esting, as it was an obvious analog of QNB, atropine, 
and related older antimuscarinics [56]. The second 
(ChEMBL-264414) was published in 2008 [57]. The mus-
carinic activity of alkyne linked quinuclidines was a surprise 
to researchers working toward novel bladder agents, and 
the selectivity profile suggested potential toward a COPD 
indication. This scaffold was different from any within the 
expanded training set for model refinement. The third com-
pound, ChEMBL-583027, was reported in 2010 [58]. It was 
one of a group of pyrrolidinylfurans, of which two potent 
examples were identified by the unrefined model (ChEMBL 
compounds 571121 and 569760, predicted at 8.1 and 9.5, 
respectively, with actual pK i  values of 8.3 and 8.0). The 
refined model, in addition to identifying ChEMBL-583027, 
also identified four other actives of this scaffold correctly.
The last compound (lower right) was identified through 
pharmacophoric modeling and virtual screening, reported 
in 2013 [59]. Of the 28 compounds from in that study, 12 
were represented within the ChEMBL data set with reported 
pKi ≥ 7.5 . The initial unrefined QuanSA model identified 
one-third of these (ChEMBL molecules 37372 and 517712 
with experimental pKi > 9.0 , and 2377261 and 2377269, 
both with pKi very close to 8.0).
The refined model identified three more with activity pre-
dictions ≥ 7.5 . This included ChEMBL molecule 3085495 
shown in Fig.  17. ChEMBL molecules 2106570 and 
2377268 were predicted to have pKi  values of 8.5 and 7.5 
and had experimental activities of 8.8, and 7.5, respectively. 
The remaining five ChEMBL compounds (1231, 2377387, 
1490, 1123, 2377267, all with experimental pKi ≥ 7.5) were 
predicted with pKi = 6.5–6.9. The QuanSA model would 
have identified all of the potent compounds as in-model win-
ners in a screen with the threshold set as pKpred
i
≥ 6.5 , with 
an extremely low false positive rate (3/1000 ZINC decoys 
are identified by this procedure at this predicted activity 
threshold).
In all cases of predicted and confirmed active molecules, 
even for those with divergent scaffolds from all training 
examples, the pose predictions were consistent across mul-
tiple variants and were convincing in the light of the SAR 
available.
Conclusions
We have described a new QSAR method, called QuanSA, 
which is a hybrid of sorts combining aspects of Compass 
and QMOD, two antecedent methods. QuanSA, however, is 
more sophisticated than either, being more physically realis-
tic than Compass in every respect and allowing for modeling 
the subtleties of protein pocket variation in a pocket-field 
in ways that QMOD could not. The approach addresses the 
question of molecular pose completely automatically, includ-
ing a means to select from among alternative molecular 
alignments. Ligand strain is modeled in a realistic manner, 
and calculations applying a pocket-field to new molecules 
make predictions of affinity, pose, and produce metrics that 
quantify the degree to which the data underlying a model 
support a prediction.
The approach was applied on sixteen separate data sets, 
eight of which allowed for direct comparison with the FEP 
method, four of which allowed for extensive testing on large 
ChEMBL data sets, and two of which place the results in 
context within the QSAR literature. The sets cover phar-
maceutically relevant targets, including serine and aspartyl 
Fig. 17  In-model QuanSA predictions of potent muscarinic antago-
nists of diverse scaffolds.
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proteases, kinases, esterases, phosphatases, other enzymes, 
ligand-gated ion channels, and GPCRs. Predictive perfor-
mance tracked with prediction difficulty. On the types of 
predictions suitable for FEP-style calculations, mean abso-
lute error was roughly 0.5 pKd units (0.7 kcal/mol), with 
some particular cases approaching chemical accuracy. For 
challenging cases by conventional QSAR standards, typical 
errors on blind test molecules were about 0.7 log units (0.9 
kcal/mol). In cases where it was possible to test QuanSA 
models on large sets of ChEMBL data, typical errors were 
higher, ranging from 0.9–1.5 log units (1.2–2.0 kcal/mol), 
but the models were able to identify potent and structurally 
novel molecules with high specificity and produced highly 
statistically significant rank orderings of potency.
In a detailed examination of an application scenario in 
which limited data were available (two series from a single 
discovery effort plus a handful of well-known contempora-
neously available examples), a QuanSA model was able to 
induce an accurate model. This model matched, to a remark-
able degree, the structure of the target’s binding pocket, pub-
lished two decades after the lead optimization effort took 
place. Even difficult aspects of SAR were explained by the 
interplay between the induced pocket-field and the ligands 
under investigation.
The critical deviation of QuanSA from the large variety of 
QSAR methods is that it approaches building causal models. 
The models do not simply correlate with activity. They are 
physically realistic manifestations into which low-energy 
conformations of ligands must fit. However, this represents 
only a step in the right direction. Aspects of protein-ligand 
interactions that involve subtleties of entropy or kinetics are 
beyond what is currently envisioned within the scope of the 
method.
There are a number of areas for further improvement and 
validation. In particular, the speed of application to new mol-
ecules (typically tens of seconds) could be optimized further, 
especially toward large-scale evaluation of synthetic ideas. 
Most importantly, the multiple ligand alignment process 
could be optimized with respect to its objective function, 
which trades off mutual similarity, volume compactness, and 
ligand strain. Extensive optimization and validation of that 
procedure on a large number of targets is planned.
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